English

INSPIRE PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2011-05-10

48 filing records in this dataset, filed from 2000-09-14 to 2011-05-10. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

21.1 million USD

2011-03-31 · USD

Exact inputs and evidence

Revenue: 21094000 USD Source

Operating margin

-84.04%

2011-03-31 · %

Exact inputs and evidence

Operating Income: -17728000 USD Source
Revenue: 21094000 USD Source

Operating cash flow

-15 million USD

2011-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -15022000 USD Source

Free cash flow

-16.8 million USD

2011-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: -15022000 USD Source
Capital Expenditure: 1755000 USD Source

Cash and cash equivalents: 31.2 million USD 2011-03-31 Source
Exact value

31188000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

105 million USD

2010-04-01 – 2011-03-31

Exact inputs and evidence

Revenue: 27272000 USD · 2010-04-01 – 2010-06-30 Source
Revenue: 26732000 USD · 2010-07-01 – 2010-09-30 Source
Revenue: 106399000 USD · 2010-01-01 – 2010-12-31 Source
Revenue: 76072000 USD · 2010-01-01 – 2010-09-30 Source
Revenue: 21094000 USD · 2011-01-01 – 2011-03-31 Source

Net income

-38.3 million USD

2010-04-01 – 2011-03-31

Exact inputs and evidence

Net income: -8848000 USD · 2010-04-01 – 2010-06-30 Source
Net income: -7558000 USD · 2010-07-01 – 2010-09-30 Source
Net income: -35447000 USD · 2010-01-01 – 2010-12-31 Source
Net income: -31193000 USD · 2010-01-01 – 2010-09-30 Source
Net income: -17622000 USD · 2011-01-01 – 2011-03-31 Source

Operating cash flow

-14.6 million USD

2010-04-01 – 2011-03-31

Exact inputs and evidence

Operating cash flow: -10833000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -7089000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -12387000 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -10833000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -6667000 USD · 2010-01-01 – 2010-12-31 Source
Operating cash flow: -12387000 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -15022000 USD · 2011-01-01 – 2011-03-31 Source

Capital expenditure

4.25 million USD

2010-04-01 – 2011-03-31

Exact inputs and evidence

Capital expenditure: 2156000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 2000000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 2391000 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 2156000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 4498000 USD · 2010-01-01 – 2010-12-31 Source
Capital expenditure: 2391000 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 1755000 USD · 2011-01-01 – 2011-03-31 Source

Free cash flow

-18.9 million USD

2010-04-01 – 2011-03-31

Exact inputs and evidence

Operating cash flow: -10833000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -7089000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: -12387000 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -10833000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: -6667000 USD · 2010-01-01 – 2010-12-31 Source
Operating cash flow: -12387000 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: -15022000 USD · 2011-01-01 – 2011-03-31 Source
Capital expenditure: 2156000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 2000000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 2391000 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 2156000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 4498000 USD · 2010-01-01 – 2010-12-31 Source
Capital expenditure: 2391000 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 1755000 USD · 2011-01-01 – 2011-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-05-10.

Financial data available through: 2010-12-31.

Coverage by financial measure

Revenue: 9 of 11 periods available· newest 2010-12-31
Operating income: 11 of 11 periods available· newest 2010-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 11 of 11 periods available· newest 2010-12-31
Capital expenditure: 11 of 11 periods available· newest 2010-12-31
Total assets: 9 of 11 periods available· newest 2010-12-31
Total liabilities: 9 of 11 periods available· newest 2010-12-31
Current assets: 9 of 11 periods available· newest 2010-12-31
Current liabilities: 9 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 9 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+15.5%

Prior period

USD 92.16 million

2009-01-01 – 2009-12-31
Current period

USD 106.4 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

106399000 − 92159000 = 14240000 USD

92159000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
106399000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · INSPIRE PHARMACEUTICALS INC · 2010-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Year-over-year change in Revenue: 14240000 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 106399000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#7361 Input fundies:Revenue: 92159000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#7361
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 4.53 million

Prior period

−USD 39.98 million

2009-01-01 – 2009-12-31
Current period

−USD 35.45 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-35447000 − -39976000 = 4529000 USD

-39976000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-35447000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · INSPIRE PHARMACEUTICALS INC · 2010-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Year-over-year change in Net income: 4529000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -35447000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#7760 Input fundies:NetIncome: -39976000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#7760
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 26.83 million

Prior period

−USD 33.5 million

2009-01-01 – 2009-12-31
Current period

−USD 6.67 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

-6667000 − -33501000 = 26834000 USD

-33501000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
-6667000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · INSPIRE PHARMACEUTICALS INC · 2010-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Year-over-year change in Operating cash flow: 26834000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -6667000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8040 Input fundies:OperatingCashFlow: -33501000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8040
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+151.1%

Prior period

USD 1.79 million

2009-01-01 – 2009-12-31
Current period

USD 4.5 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

4498000 − 1791000 = 2707000 USD

1791000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
4498000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · INSPIRE PHARMACEUTICALS INC · 2010-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Year-over-year change in Capital expenditure: 2707000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 4498000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8110 Input fundies:CapitalExpenditure: 1791000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8110
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 106.4 million 100% of revenue
Operating costs Derived USD 142.15 million 134% of revenue
Operating income −USD 35.76 million −34% of revenue
Tax, interest and other Derived −USD 308,000 −0.3% of revenue
Net income −USD 35.45 million −33% of revenue

Cash

Operating cash flow −USD 6.67 million −6.3% of revenue
Capital expenditure USD 4.5 million 4.2% of revenue
Free cash flow Derived −USD 11.17 million −10% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2002 Operating loss: operating costs were 622% of revenue.
2003 Operating loss: operating costs were 721% of revenue.
2004 Operating loss: operating costs were 511% of revenue.
2005 Operating loss: operating costs were 253% of revenue.
2006 Operating loss: operating costs were 226% of revenue.
2007 Operating loss: operating costs were 235% of revenue.
2008 Operating loss: operating costs were 170% of revenue.
2009 Operating loss: operating costs were 141% of revenue.
2010 Operating loss: operating costs were 134% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2002 2002-01-01 – 2002-12-31	4883000	30380000 Derived	-25497000	-804000 Derived	-24693000	-25854000 Derived	Source 2002-01-01 – 2002-12-31: 4883000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -25497000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -24693000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -25625000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 229000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	5200000	37471000 Derived	-32271000	-876000 Derived	-31395000	-29154000 Derived	Source 2003-01-01 – 2003-12-31: 5200000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -32271000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -31395000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -27961000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 1193000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	11068000	56587000 Derived	-45519000	-1450000 Derived	-44069000	-40100000 Derived	Source 2004-01-01 – 2004-12-31: 11068000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -45519000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -44069000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -40100000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 0 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	23266000	58793000 Derived	-35527000	-3680000 Derived	-31847000	-34407000 Derived	Source 2005-01-01 – 2005-12-31: 23266000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -35527000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -31847000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -33759000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 648000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	37059000	83682000 Derived	-46623000	-4508000 Derived	-42115000	-40129000 Derived	Source 2006-01-01 – 2006-12-31: 37059000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -46623000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -42115000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -39275000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 854000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	48665000	114542000 Derived	-65877000	-2137000 Derived	-63740000	-53839000 Derived	Source 2007-01-01 – 2007-12-31: 48665000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -65877000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -63740000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -51869000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 1970000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	70498000	120157000 Derived	-49659000	1944000 Derived	-51603000	-52516000 Derived	Source 2008-01-01 – 2008-12-31: 70498000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -49659000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -51603000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -51471000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 1045000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	92159000	129776000 Derived	-37617000	2359000 Derived	-39976000	-35292000 Derived	Source 2009-01-01 – 2009-12-31: 92159000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -37617000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -39976000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -33501000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 1791000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	106399000	142154000 Derived	-35755000	-308000 Derived	-35447000	-11165000 Derived	Source 2010-01-01 – 2010-12-31: 106399000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -35755000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -35447000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -6667000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 4498000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 106.4M 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Revenue	4883000	Revenue: 4883000 Open source
20032003-12-31	Revenue	5200000	Revenue: 5200000 Open source
20042004-12-31	Revenue	11068000	Revenue: 11068000 Open source
20052005-12-31	Revenue	23266000	Revenue: 23266000 Open source
20062006-12-31	Revenue	37059000	Revenue: 37059000 Open source
20072007-12-31	Revenue	48665000	Revenue: 48665000 Open source
20082008-12-31	Revenue	70498000	Revenue: 70498000 Open source
20092009-12-31	Revenue	92159000	Revenue: 92159000 Open source
20102010-12-31	Revenue	106399000	Revenue: 106399000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

15.5% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Year over year	No prior comparable period	Revenue: 4883000 Open source
20032003-12-31	Year over year	6.5%	Revenue: 5200000 Open source Revenue: 4883000 Open source
20042004-12-31	Year over year	112.8%	Revenue: 11068000 Open source Revenue: 5200000 Open source
20052005-12-31	Year over year	110.2%	Revenue: 23266000 Open source Revenue: 11068000 Open source
20062006-12-31	Year over year	59.3%	Revenue: 37059000 Open source Revenue: 23266000 Open source
20072007-12-31	Year over year	31.3%	Revenue: 48665000 Open source Revenue: 37059000 Open source
20082008-12-31	Year over year	44.9%	Revenue: 70498000 Open source Revenue: 48665000 Open source
20092009-12-31	Year over year	30.7%	Revenue: 92159000 Open source Revenue: 70498000 Open source
20102010-12-31	Year over year	15.5%	Revenue: 106399000 Open source Revenue: 92159000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -33.6% 2010

Net margin -33.3% 2010

Free cash flow margin -10.5% 2010

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Operating margin	-522.2%	Operating Income: -25497000 Open source Revenue: 4883000 Open source
20032003-12-31	Operating margin	-620.6%	Operating Income: -32271000 Open source Revenue: 5200000 Open source
20042004-12-31	Operating margin	-411.3%	Operating Income: -45519000 Open source Revenue: 11068000 Open source
20052005-12-31	Operating margin	-152.7%	Operating Income: -35527000 Open source Revenue: 23266000 Open source
20062006-12-31	Operating margin	-125.8%	Operating Income: -46623000 Open source Revenue: 37059000 Open source
20072007-12-31	Operating margin	-135.4%	Operating Income: -65877000 Open source Revenue: 48665000 Open source
20082008-12-31	Operating margin	-70.4%	Operating Income: -49659000 Open source Revenue: 70498000 Open source
20092009-12-31	Operating margin	-40.8%	Operating Income: -37617000 Open source Revenue: 92159000 Open source
20102010-12-31	Operating margin	-33.6%	Operating Income: -35755000 Open source Revenue: 106399000 Open source
20022002-12-31	Net margin	-505.7%	Net Income: -24693000 Open source Revenue: 4883000 Open source
20032003-12-31	Net margin	-603.8%	Net Income: -31395000 Open source Revenue: 5200000 Open source
20042004-12-31	Net margin	-398.2%	Net Income: -44069000 Open source Revenue: 11068000 Open source
20052005-12-31	Net margin	-136.9%	Net Income: -31847000 Open source Revenue: 23266000 Open source
20062006-12-31	Net margin	-113.6%	Net Income: -42115000 Open source Revenue: 37059000 Open source
20072007-12-31	Net margin	-131%	Net Income: -63740000 Open source Revenue: 48665000 Open source
20082008-12-31	Net margin	-73.2%	Net Income: -51603000 Open source Revenue: 70498000 Open source
20092009-12-31	Net margin	-43.4%	Net Income: -39976000 Open source Revenue: 92159000 Open source
20102010-12-31	Net margin	-33.3%	Net Income: -35447000 Open source Revenue: 106399000 Open source
20022002-12-31	Free cash flow margin	-529.5%	Revenue: 4883000 Open source Operating Cash Flow: -25625000 Open source Capital Expenditure: 229000 Open source
20032003-12-31	Free cash flow margin	-560.7%	Revenue: 5200000 Open source Operating Cash Flow: -27961000 Open source Capital Expenditure: 1193000 Open source
20042004-12-31	Free cash flow margin	-362.3%	Revenue: 11068000 Open source Operating Cash Flow: -40100000 Open source Capital Expenditure: 0 Open source
20052005-12-31	Free cash flow margin	-147.9%	Revenue: 23266000 Open source Operating Cash Flow: -33759000 Open source Capital Expenditure: 648000 Open source
20062006-12-31	Free cash flow margin	-108.3%	Revenue: 37059000 Open source Operating Cash Flow: -39275000 Open source Capital Expenditure: 854000 Open source
20072007-12-31	Free cash flow margin	-110.6%	Revenue: 48665000 Open source Operating Cash Flow: -51869000 Open source Capital Expenditure: 1970000 Open source
20082008-12-31	Free cash flow margin	-74.5%	Revenue: 70498000 Open source Operating Cash Flow: -51471000 Open source Capital Expenditure: 1045000 Open source
20092009-12-31	Free cash flow margin	-38.3%	Revenue: 92159000 Open source Operating Cash Flow: -33501000 Open source Capital Expenditure: 1791000 Open source
20102010-12-31	Free cash flow margin	-10.5%	Revenue: 106399000 Open source Operating Cash Flow: -6667000 Open source Capital Expenditure: 4498000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -6.7M 2010

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Operating cash flow	-25625000	Operating Cash Flow: -25625000 Open source
20032003-12-31	Operating cash flow	-27961000	Operating Cash Flow: -27961000 Open source
20042004-12-31	Operating cash flow	-40100000	Operating Cash Flow: -40100000 Open source
20052005-12-31	Operating cash flow	-33759000	Operating Cash Flow: -33759000 Open source
20062006-12-31	Operating cash flow	-39275000	Operating Cash Flow: -39275000 Open source
20072007-12-31	Operating cash flow	-51869000	Operating Cash Flow: -51869000 Open source
20082008-12-31	Operating cash flow	-51471000	Operating Cash Flow: -51471000 Open source
20092009-12-31	Operating cash flow	-33501000	Operating Cash Flow: -33501000 Open source
20102010-12-31	Operating cash flow	-6667000	Operating Cash Flow: -6667000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -11.2M 2010

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20022002-12-31	Free cash flow	-25854000	Operating Cash Flow: -25625000 Open source Capital Expenditure: 229000 Open source
20032003-12-31	Free cash flow	-29154000	Operating Cash Flow: -27961000 Open source Capital Expenditure: 1193000 Open source
20042004-12-31	Free cash flow	-40100000	Operating Cash Flow: -40100000 Open source Capital Expenditure: 0 Open source
20052005-12-31	Free cash flow	-34407000	Operating Cash Flow: -33759000 Open source Capital Expenditure: 648000 Open source
20062006-12-31	Free cash flow	-40129000	Operating Cash Flow: -39275000 Open source Capital Expenditure: 854000 Open source
20072007-12-31	Free cash flow	-53839000	Operating Cash Flow: -51869000 Open source Capital Expenditure: 1970000 Open source
20082008-12-31	Free cash flow	-52516000	Operating Cash Flow: -51471000 Open source Capital Expenditure: 1045000 Open source
20092009-12-31	Free cash flow	-35292000	Operating Cash Flow: -33501000 Open source Capital Expenditure: 1791000 Open source
20102010-12-31	Free cash flow	-11165000	Operating Cash Flow: -6667000 Open source Capital Expenditure: 4498000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

33.2% 2010

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Liabilities / assets	13.6%	Total Liabilities: 4566000 Open source Total Assets: 33564000 Open source
20032003-12-31	Liabilities / assets	10.8%	Total Liabilities: 8626000 Open source Total Assets: 79678000 Open source
20042004-12-31	Liabilities / assets	9.7%	Total Liabilities: 16098000 Open source Total Assets: 165696000 Open source
20052005-12-31	Liabilities / assets	10.4%	Total Liabilities: 13757000 Open source Total Assets: 132446000 Open source
20062006-12-31	Liabilities / assets	32.8%	Total Liabilities: 38328000 Open source Total Assets: 116699000 Open source
20072007-12-31	Liabilities / assets	49.2%	Total Liabilities: 88810000 Open source Total Assets: 180503000 Open source
20082008-12-31	Liabilities / assets	61.1%	Total Liabilities: 69837000 Open source Total Assets: 114224000 Open source
20092009-12-31	Liabilities / assets	33.3%	Total Liabilities: 59602000 Open source Total Assets: 178770000 Open source
20102010-12-31	Liabilities / assets	33.2%	Total Liabilities: 47261000 Open source Total Assets: 142499000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.64× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20022002-12-31	Current assets / current liabilities	7.33×	Current Assets: 31965000 Open source Current Liabilities: 4362000 Open source
20032003-12-31	Current assets / current liabilities	10.71×	Current Assets: 73050000 Open source Current Liabilities: 6819000 Open source
20042004-12-31	Current assets / current liabilities	11.5×	Current Assets: 147370000 Open source Current Liabilities: 12811000 Open source
20052005-12-31	Current assets / current liabilities	10.03×	Current Assets: 110252000 Open source Current Liabilities: 10987000 Open source
20062006-12-31	Current assets / current liabilities	5.96×	Current Assets: 107746000 Open source Current Liabilities: 18091000 Open source
20072007-12-31	Current assets / current liabilities	3.57×	Current Assets: 149506000 Open source Current Liabilities: 41855000 Open source
20082008-12-31	Current assets / current liabilities	2.27×	Current Assets: 93927000 Open source Current Liabilities: 41415000 Open source
20092009-12-31	Current assets / current liabilities	2.67×	Current Assets: 136654000 Open source Current Liabilities: 51242000 Open source
20102010-12-31	Current assets / current liabilities	2.64×	Current Assets: 116724000 Open source Current Liabilities: 44233000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 23.14 million Exact value Exact value: -23135000 USD 2001-01-01 – 2001-12-31: -23135000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2001-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -23135000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23135000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-04-040690.txt#6755 The citation records this snapshot. The page link may show a newer release later.	−USD 20.47 million Exact value Exact value: -20472000 USD 2001-01-01 – 2001-12-31: -20472000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2001-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -20472000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -20472000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-04-040690.txt#7061 The citation records this snapshot. The page link may show a newer release later.	USD 496,000 Exact value Exact value: 496000 USD 2001-01-01 – 2001-12-31: 496000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2001-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 496000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 496000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-04-040690.txt#7187 The citation records this snapshot. The page link may show a newer release later.	−USD 20.97 million Calculation and evidence -20472000 − 496000 USD Exact free cash flow: -20968000 USD 2001-01-01 – 2001-12-31: -20472000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 496000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2001-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -20968000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -20472000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-04-040690.txt#7061 Input fundies:CapitalExpenditure: 496000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-04-040690.txt#7187 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 24.69 million Exact value Exact value: -24693000 USD 2002-01-01 – 2002-12-31: -24693000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2002-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -24693000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -24693000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-05-047600.txt#6183 The citation records this snapshot. The page link may show a newer release later.	−USD 25.63 million Exact value Exact value: -25625000 USD 2002-01-01 – 2002-12-31: -25625000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2002-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -25625000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -25625000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-05-047600.txt#6379 The citation records this snapshot. The page link may show a newer release later.	USD 229,000 Exact value Exact value: 229000 USD 2002-01-01 – 2002-12-31: 229000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2002-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 229000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 229000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-05-047600.txt#6463 The citation records this snapshot. The page link may show a newer release later.	−USD 25.85 million Calculation and evidence -25625000 − 229000 USD Exact free cash flow: -25854000 USD 2002-01-01 – 2002-12-31: -25625000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 229000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2002-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -25854000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25625000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-05-047600.txt#6379 Input fundies:CapitalExpenditure: 229000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-05-047600.txt#6463 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 31.4 million Exact value Exact value: -31395000 USD 2003-01-01 – 2003-12-31: -31395000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2003-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -31395000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31395000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-06-056514.txt#6398 The citation records this snapshot. The page link may show a newer release later.	−USD 27.96 million Exact value Exact value: -27961000 USD 2003-01-01 – 2003-12-31: -27961000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2003-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -27961000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -27961000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-06-056514.txt#6594 The citation records this snapshot. The page link may show a newer release later.	USD 1.19 million Exact value Exact value: 1193000 USD 2003-01-01 – 2003-12-31: 1193000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2003-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 1193000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1193000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-06-056514.txt#6678 The citation records this snapshot. The page link may show a newer release later.	−USD 29.15 million Calculation and evidence -27961000 − 1193000 USD Exact free cash flow: -29154000 USD 2003-01-01 – 2003-12-31: -27961000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 1193000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2003-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -29154000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27961000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-06-056514.txt#6594 Input fundies:CapitalExpenditure: 1193000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-06-056514.txt#6678 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 44.07 million Exact value Exact value: -44069000 USD 2004-01-01 – 2004-12-31: -44069000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2004-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -44069000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -44069000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#6985 The citation records this snapshot. The page link may show a newer release later.	−USD 40.1 million Exact value Exact value: -40100000 USD 2004-01-01 – 2004-12-31: -40100000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2004-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -40100000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -40100000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#7181 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2004-01-01 – 2004-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2004-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#7251 The citation records this snapshot. The page link may show a newer release later.	−USD 40.1 million Calculation and evidence -40100000 − 0 USD Exact free cash flow: -40100000 USD 2004-01-01 – 2004-12-31: -40100000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2004-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -40100000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -40100000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#7181 Input fundies:CapitalExpenditure: 0 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#7251 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 31.85 million Exact value Exact value: -31847000 USD 2005-01-01 – 2005-12-31: -31847000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2005-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -31847000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -31847000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-08-057484.txt#7522 The citation records this snapshot. The page link may show a newer release later.	−USD 33.76 million Exact value Exact value: -33759000 USD 2005-01-01 – 2005-12-31: -33759000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2005-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -33759000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33759000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#7181 The citation records this snapshot. The page link may show a newer release later.	USD 648,000 Exact value Exact value: 648000 USD 2005-01-01 – 2005-12-31: 648000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2005-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 648000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 648000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#7251 The citation records this snapshot. The page link may show a newer release later.	−USD 34.41 million Calculation and evidence -33759000 − 648000 USD Exact free cash flow: -34407000 USD 2005-01-01 – 2005-12-31: -33759000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 648000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2005-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -34407000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33759000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#7181 Input fundies:CapitalExpenditure: 648000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-07-056641.txt#7251 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 42.12 million Exact value Exact value: -42115000 USD 2006-01-01 – 2006-12-31: -42115000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2006-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -42115000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -42115000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-09-053891.txt#6604 The citation records this snapshot. The page link may show a newer release later.	−USD 39.28 million Exact value Exact value: -39275000 USD 2006-01-01 – 2006-12-31: -39275000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2006-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -39275000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -39275000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-09-053891.txt#6856 The citation records this snapshot. The page link may show a newer release later.	USD 854,000 Exact value Exact value: 854000 USD 2006-01-01 – 2006-12-31: 854000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2006-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 854000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 854000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-09-053891.txt#6954 The citation records this snapshot. The page link may show a newer release later.	−USD 40.13 million Calculation and evidence -39275000 − 854000 USD Exact free cash flow: -40129000 USD 2006-01-01 – 2006-12-31: -39275000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 854000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2006-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -40129000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -39275000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-09-053891.txt#6856 Input fundies:CapitalExpenditure: 854000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-09-053891.txt#6954 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 63.74 million Exact value Exact value: -63740000 USD 2007-01-01 – 2007-12-31: -63740000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2007-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -63740000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -63740000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-10-057177.txt#7377 The citation records this snapshot. The page link may show a newer release later.	−USD 51.87 million Exact value Exact value: -51869000 USD 2007-01-01 – 2007-12-31: -51869000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2007-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -51869000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51869000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-10-057177.txt#7643 The citation records this snapshot. The page link may show a newer release later.	USD 1.97 million Exact value Exact value: 1970000 USD 2007-01-01 – 2007-12-31: 1970000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2007-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 1970000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1970000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-10-057177.txt#7741 The citation records this snapshot. The page link may show a newer release later.	−USD 53.84 million Calculation and evidence -51869000 − 1970000 USD Exact free cash flow: -53839000 USD 2007-01-01 – 2007-12-31: -51869000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 1970000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2007-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -53839000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51869000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-10-057177.txt#7643 Input fundies:CapitalExpenditure: 1970000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-10-057177.txt#7741 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 51.6 million Exact value Exact value: -51603000 USD 2008-01-01 – 2008-12-31: -51603000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2008-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -51603000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51603000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#7760 The citation records this snapshot. The page link may show a newer release later.	−USD 51.47 million Exact value Exact value: -51471000 USD 2008-01-01 – 2008-12-31: -51471000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2008-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -51471000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -51471000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8040 The citation records this snapshot. The page link may show a newer release later.	USD 1.05 million Exact value Exact value: 1045000 USD 2008-01-01 – 2008-12-31: 1045000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2008-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 1045000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1045000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8110 The citation records this snapshot. The page link may show a newer release later.	−USD 52.52 million Calculation and evidence -51471000 − 1045000 USD Exact free cash flow: -52516000 USD 2008-01-01 – 2008-12-31: -51471000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 1045000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2008-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -52516000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -51471000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8040 Input fundies:CapitalExpenditure: 1045000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8110 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 39.98 million Exact value Exact value: -39976000 USD 2009-01-01 – 2009-12-31: -39976000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2009-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -39976000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -39976000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#7760 The citation records this snapshot. The page link may show a newer release later.	−USD 33.5 million Exact value Exact value: -33501000 USD 2009-01-01 – 2009-12-31: -33501000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2009-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -33501000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -33501000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8040 The citation records this snapshot. The page link may show a newer release later.	USD 1.79 million Exact value Exact value: 1791000 USD 2009-01-01 – 2009-12-31: 1791000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2009-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 1791000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1791000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8110 The citation records this snapshot. The page link may show a newer release later.	−USD 35.29 million Calculation and evidence -33501000 − 1791000 USD Exact free cash flow: -35292000 USD 2009-01-01 – 2009-12-31: -33501000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 1791000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2009-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -35292000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33501000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8040 Input fundies:CapitalExpenditure: 1791000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8110 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 35.45 million Exact value Exact value: -35447000 USD 2010-01-01 – 2010-12-31: -35447000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INSPIRE PHARMACEUTICALS INC · 2010-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Net Income: -35447000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -35447000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#7760 The citation records this snapshot. The page link may show a newer release later.	−USD 6.67 million Exact value Exact value: -6667000 USD 2010-01-01 – 2010-12-31: -6667000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INSPIRE PHARMACEUTICALS INC · 2010-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Operating Cash Flow: -6667000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6667000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8040 The citation records this snapshot. The page link may show a newer release later.	USD 4.5 million Exact value Exact value: 4498000 USD 2010-01-01 – 2010-12-31: 4498000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INSPIRE PHARMACEUTICALS INC · 2010-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Capital Expenditure: 4498000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4498000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8110 The citation records this snapshot. The page link may show a newer release later.	−USD 11.17 million Calculation and evidence -6667000 − 4498000 USD Exact free cash flow: -11165000 USD 2010-01-01 – 2010-12-31: -6667000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 4498000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INSPIRE PHARMACEUTICALS INC · 2010-12-31 INSPIRE PHARMACEUTICALS INC (edgar:1040416) Free cash flow: -11165000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T15:03:24Z Snapshot: f0642e2f8e3c1454a7b9472e439af165a41c27879d670dcf19765bd182561ef2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1040416?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6667000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8040 Input fundies:CapitalExpenditure: 4498000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1040416/0001193125-11-047354.txt#8110 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

48 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001040416, 1040416, edgar:1040416

INSPIRE PHARMACEUTICALS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation